Doping capsules, composite systems comprising these and also use thereof

US2016202500A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016202500-A1
Application numberUS-201615080312-A
CountryUS
Kind codeA1
Filing dateMar 24, 2016
Priority dateDec 20, 2007
Publication dateJul 14, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to doping capsules which have a substance which displays a decreasing transparency with increasing temperature within a defined temperature range due to physicochemical interactions with the polymer matrix to be doped. Likewise, the invention relates to composite systems which have a polymer matrix doped with the doping capsules. The capsules according to the invention are used for sun protection or heat reflection.

First claim

Opening claim text (preview).

1 - 18 . (canceled) 19 . A method for sun protection and/or heat reflection comprising utilizing doping capsules comprising at least one substance which has a rotator phase in a temperature range of 10 to 55° C., the capsules displaying a decrease in transparency in the temperature range with increasing temperature wherein the at least one substance is present as a separate phase and in monodisperse form. 20 . The method according to claim 19 , wherein the at least one substance has a rotator phase in the temperature range of 15 to 45° C. 21 . The method according to claim 19 , wherein a plastic crystalline phase is formed in the temperature range. 22 . The method according to claim 19 , wherein the at least one substance is selected from the group of saturated or unsaturated hydrocarbons. 23 . The method according to claim 19 , wherein the at least one substance is selected from the group consisting of saturated or unsaturated aliphatic hydrocarbons (C 10 -C 30 ), saturated or unsaturated fatty alcohols and fatty amines, esters of fatty acids and halogenated hydrocarbons, cholesteryl compounds, polyolefins, organometals, and also mixtures hereof. 24 . The method according to claim 19 , wherein the capsule comprises in addition substances without a rotator phase. 25 . The method according to claim 19 , wherein the capsules are microcapsules and have a diameter in the range of 1 to 10 μm. 26 . The method according to claim 19 , wherein the capsules are nanocapsules and have a diameter in the range of 10 nm to 1 μm. 27 . The method according to claim 25 , wherein the capsules consist of a mixture of microcapsules and nanocapsules. 28 . The method according to claim 19 , wherein the at least one substance comprises saturated or unsaturated aliphatic hydrocarbons (C 10 -C 30 ) comprising n-tetradecane, n-eicosane, n-nonadecane, n-heptacosane, hexadecane or any combination thereof. 29 . The method according to claim 19 , wherein the at least one substance comprises saturated or unsaturated fatty alcohol and/or fatty amine comprising dodecyl alcohol, decyl alcohol, hexadecyl alcohol, dodecylamine, decylamine, hexadecylamine, or any comnination thereof. 30 . The method according to claim 19 , wherein the at least one substance comprises esters of fatty acids and/or halogenated hydrocarbon comprising C 14 -C 26 fatty acid esters, C 14 -C 26 hydrocarbons, perfluoroalkanes, or any combination thereof. 31 . The method according to claim 19 , wherein the at least one substance comprises cholesteryl compound comprising cholesterol monohydrate, cholesteryl acetate, stigmasterol or any combination thereof. 32 . The method according to claim 19 , wherein the at least one substance comprises polyolefin comprising polyethylene, polypropylene, copolymers thereof, or any combination thereof. 33 . The method according to claim 19 , wherein the at least one substance comprises organometal comprising octamethyl ferrocene.

Assignees

Inventors

Classifications

  • based on thermo-optic effects (G02F1/132 takes precedence) · CPC title

  • Particulate matter [e.g., sphere, flake, etc.] · CPC title

  • Making microcapsules or microballoons {(for medical preparations A61K9/50)} · CPC title

  • Solid spheres · CPC title

  • Structure, phase transitions, NMR, ESR, Moessbauer spectra · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016202500A1 cover?
The invention relates to doping capsules which have a substance which displays a decreasing transparency with increasing temperature within a defined temperature range due to physicochemical interactions with the polymer matrix to be doped. Likewise, the invention relates to composite systems which have a polymer matrix doped with the doping capsules. The capsules according to the invention are…
Who is the assignee on this patent?
Fraunhofer Ges Forschung
What technology area does this patent fall under?
Primary CPC classification G02F1/009. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Jul 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).